FY2025 EPS Estimates for uniQure Lowered by Chardan Capital
uniQure (NASDAQ:QURE – Free Report) – Research analysts at Chardan Capital cut their FY2025 earnings per share (EPS) estimates for shares of uniQure in a research note issued on Monday, May 12th. Chardan Capital analyst D. Gataulin now forecasts that the biotechnology company will earn ($4.04) per share for the year, down from their prior […]
uniQure (NASDAQ:QURE – Free Report) – Research analysts at Chardan Capital cut their FY2025 earnings per share (EPS) estimates for shares of uniQure in a research note issued on Monday, May 12th. Chardan Capital analyst D. Gataulin now forecasts that the biotechnology company will earn ($4.04) per share for the year, down from their prior […]
